Tocieta 25 mg filmom obložene tablete
| Name | Tocieta 25 mg filmom obložene tablete |
|---|---|
| Former Name | Mining 25 mg filmom obložene tablete |
| Marketing Authorisation Number | HR-H-491414261 |
| Active Substance | eltrombopagolamin |
| Composition | jedna filmom obložena tableta sadrži 25 mg eltrombopaga u obliku eltrombopagolamina |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Synthon Hispania S.L., Sant Boi de Llobregat, Španjolska Synthon BV, Nijmegen, Nizozemska |
| Marketing Authorisation Holder | Zentiva k.s., U Kabelovny 130, Dolni Mecholupy, Prag 10, Češka |
| Marketing Authorisation Date | 17.01.2024 |
| MA Period of Validity | 17.01.2029 |
| Classification Number | UP/I-530-09/22-01/279 |
| Registration Number | 381-12-01/70-24-08 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | B02BX05 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
